Funder
National Natural Science Foundation of China
Reference35 articles.
1. A review of cancer immunotherapy toxicity;Kennedy;Ca - Cancer J. Clin.,2020
2. Nivolumab plus ipilimumab in advanced non-small-cell lung cancer;Hellmann;N. Engl. J. Med.,2019
3. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma;Raje;N. Engl. J. Med.,2019
4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
5. Comprehensive analysis of the clinical immuno-oncology landscape;Tang;Ann. Oncol.,2018
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献